RxDoctor Payments Data

Brad Ruetenik

Foot & Ankle Surgery · Encinitas, CANPI 1093706590

Payments from drug & device makers

$3,690in general payments, 2019–2025

Across 26 payments — averaging $141.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elevate Surgical Co$2K
  • Sportstek Medical, Inc$485
  • Stryker$234
  • Treace Medical Concepts, Inc.$206
  • Organogenesis Inc.$148
  • Biotissue Holdings Inc.$74
  • plus $85 from 3 others

What the payments were for

  • Food & beverage$80522%
  • Education$2,88578%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Elevate Surgical Co3$2,459
Sportstek Medical, Inc1$485
Stryker(2 entities)8$234
Treace Medical Concepts, Inc.6$206
Organogenesis Inc.4$148
Biotissue Holdings Inc.1$74
Zimmer Biomet1$32
Integra Lifesciences Corporation1$28
Kerecis Limited1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,690 in reported general payments places this provider in the 60th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California

Medicare billing

Part B allowed, 2024
$114,881
Medicare patients
370
Services billed
1,442

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort16$722
Econazole Nitrate13$124
Gabapentin14$24

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Encinitas

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →